GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
Genomic Prediction Inc.
Study ID
NCT06141135
Status
Recruiting
Apply to this trial

Conditions

  • Infertility, Female

Eligibility Criteria

Sex
FEMALE
Age
35 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

  • Preimplantation genetic testing for aneuploidy (PGTA) — OTHER
    24 chromosome screening for aneuploidy in the preimplantation embryo(blastocyst stage)

Study Details

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Key Dates

Start date
Nov 15, 2023
Status verified
Aug 2025
Primary completion
Nov 15, 2025
Completion
Nov 15, 2026

Study Design

Enrollment
240 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Experimental Arm - Transfer of Best Quality, Euploid Blastocyst
    Transfer of best quality, PGTA normal (euploid) blastocyst.
  • No Intervention: Control Arm - Transfer of Untested, Best Quality Blastocyst
    Transfer of Untested, Best Quality Blastocyst

Primary Outcome Measure

Ongoing Pregnancy Rate [ Time Frame: Up to 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Boston IVFWalthamMassachusetts02451
Kristin Rooney
[email protected]
(781) 434-6500
Kim Thorton, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Waltham, MA

By research site
Boston IVF· Waltham, MA

Related Studies